NK cell therapy
Immune cells grown in a lab and infused back, sold as immune rejuvenation. The serious science sits in cancer, and it is still unfinished.
Availability Offered in select countries
What it is
Natural killer cells destroy infected and abnormal cells without needing to be trained on them first. NK cell therapy draws your blood, expands and activates the NK fraction in a lab over roughly two weeks, then infuses billions of them back. Some clinics use donor cells instead.
Why people choose this treatment
The pitch is immune surveillance. NK activity does decline with age, and clinics extend that into claims about clearing senescent cells, catching cancer early, and rebuilding resilience. For someone who has watched an immune system fail in their family, that is intuitive.
How it's delivered
Two visits several weeks apart, usually in Mexico, Japan, or Southeast Asia: a blood draw, then an IV infusion under an hour, usually a course of two to six. Mexican clinics work under COFEPRIS rather than FDA and generally disclose that their cell products are unapproved.
Where the evidence stands
NK cells are a genuine, active area of cancer research. Expanded and engineered NK trials are running in leukemia, lymphoma, and solid tumors, and none has reached late-phase approval. The nearest approved product, Anktiva, is a drug that activates NK cells inside the bladder, not an infused cell. For aging, no controlled trial has shown that infusing NK cells clears senescent cells, prevents cancer, or moves any aging outcome in humans.
Estimated cost
- $15,000–$50,000 per course, Mexico clinics
- Up to $90,000 at premium destinations
- Prices rarely published; quoted after consult
- Not covered by insurance
Who offers it
Observed at the Longevity Medical Institute, Cellular Hope Institute, and GIOSTAR in Mexico, and at immune-cell clinics in Japan. All operate outside FDA oversight.
Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.
Go deeper
Our regenerative therapies hub covers the cell-therapy market, what the offshore tier sells, and how to read a clinic's claims against the trial record.
Longevity.io is for educational purposes only and is not medical advice. If you are considering NK cell therapy for a cancer diagnosis, that decision belongs with your oncologist, alongside the treatments that have survival data behind them. Confirm eligibility, services, and pricing directly with any provider.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
